Publications

Educators

Mar 2012
Article

How to Make Finance Work

crisis. Second, trillions of dollars have been steered into residential real estate and away from more productive investments. Third, the cost of professional investment management is too high, which drains talent from other industries. The financial sector could... View Details

Web

Driving Social Change | Social Enterprise | Harvard Business School

Driving Social Change Background I’ve always been interested in public sector issues and what we call “institutional change,” especially change that breaks with the accepted norms. I studied the English National Health Service, focusing... View Details

10 Jan 2005
What Do You Think?

Public Pension Reform: Does Mexico Have the Answer?

Summing Up Judging from responses to the January column, the debate concerning reform of the social security system in the U.S. will take many directions before the question can even be framed adequately. If the responses are an... View Details

Keywords: by James Heskett; Financial Services

28 Jun 2011
News

Beyond Case Writing

interest in global health to the realization that an estimated 13 million people die each year for lack of low-cost products that could save their lives. Over the past seven years, she has conducted research projects in Zambia aimed at... View Details

Keywords: Roger Thompson; Ambulatory Health Care Services; Ambulatory Health Care Services; Ambulatory Health Care Services; Ambulatory Health Care Services

10 Aug 2011
Research & Ideas

HBS Faculty Views on Debt Crisis

of perhaps $90 trillion. One side argues that we can't raise revenues, while the other asserts we can't cut entitlements. Both sides are wrong. Entitlement costs, especially health care, will eat us alive. Without real View Details

Keywords: by Staff

April 2011 (Revised October 2011)
Teaching Note

U.S. Healthcare Reform: International Perspectives (TN)

By: Arthur A. Daemmrich and Elia Cameron

Teaching Note for #710-040 and 711-103. View Details

Keywords: Health Care and Treatment; Governing Rules, Regulations, and Reforms; United States

Article

The CMS New Rule on Ambulatory Surgical Centers Earns Only Partial Credit

By: Junaid Nabi and Robert S. Kaplan

The Centers of Medicare and Medicaid Services (CMS) recently announced that it will be removing more... View Details

Keywords: Ambulatory Care; Payment Policy; Health Care and Treatment; Governing Rules, Regulations, and Reforms

Read Now

23 Jul 2013
First Look

First Look: July 23

School Case 713-483 Yammer (B) Supplement to "Yammer (A)," HBS case 713-407 Purchase this case: http://hbr.org/search/713483-PDF-ENG Harvard Business School Case 712-466 Moving to Universal Coverage: Health Care View Details

Keywords: Anna Secino

01 Sep 2010
News

RX for Change

employs 9,000 people and ranks as Georgia’s largest, most comprehensive health system. Under consideration this day is a proposal to add specialists — known as neurohospitalists — to manage care for patients with disorders such as stroke.... View Details

Keywords: Julia Hanna; Health, Social Assistance; Hospitals; Health, Social Assistance

29 Jan 2015
Op-Ed

The Fall of Greece

Professor of Business Administration and a native of Greece, offers his insights into what the election means for the country. Many people ask me what the recent elections in Greece mean for the Greek economy. While I agree reforms are... View Details

Keywords: by George Serafeim

October 2024
Article

Medicare Part D Protected-Class Policy Is Associated with Lower Drug Rebates

By: Pragya Kakani, Michael Anne Kyle, Amitabh Chandra and Luca Maini

Medicare Part D does not allow plans to exclude drugs in six protected classes from their formularies, which may limit plans’ ability to negotiate rebates and lead to higher spending. We estimated the association between protected-class status, US-level estimated... View Details

Keywords: Insurance; Health Care and Treatment; Governing Rules, Regulations, and Reforms; United States

June 9, 2023
Article

A Radical Treatment for Insulin Pricing

By: Leemore S. Dafny

In 2021, the Food and Drug Administration (FDA) approved the first interchangeable biosimilar for long-acting insulin, which many hoped would be substantially cheaper than the reference branded product. I explain why prices have barely changed, and argue that a... View Details

Keywords: Biosimilars; Rebates; Pharmaceuticals; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; United States

Register to Read

July 2019
Article

The Impact of Price Regulation on the Availability of New Drugs in Germany

By: Ariel Dora Stern, Felicitas Pietrulla, Annika Herr, Aaron S. Kesselheim and Ameet Sarpatwari

The 2011 German Pharmaceutical Market Restructuring Act (“AMNOG”) subjected branded, non-rare disease drugs to price regulation based on an assessment of their clinical benefit. Assessment outcomes range from “major added benefit” to “less benefit than the appropriate... View Details

Keywords: Regulation; Pharmaceuticals; Healthcare; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Germany

Read Now

2024
Working Paper

Fecal Microbiota Transplants —Too Simple to be Safe? Case Histories of Transformational Advances

By: Amar Bhide and Srikant M. Datar

By 2013, after many decades of very slow development and adoption, Fecal Microbiota Transplantation procedures were attracting widespread attention. This case history chronicles the: 1) pioneering fecal transplants performed in the 20th century; 2) development of the... View Details

Keywords: Health Care and Treatment; Innovation and Invention; Governing Rules, Regulations, and Reforms

SSRN

Read Now

26 Jul 2016
Working Paper Summaries

The Impact of the Entry of Biosimilars: Evidence from Europe

Keywords: by Fiona Scott Morton, Ariel Dora Stern, and Scott Stern; Health; Health; Health

2023
Working Paper

The Political Economy of a 'Miracle Cure': The Case of Nebulized Ibuprofen and Its Diffusion in Argentina

By: Sebastian Calónico, Rafael Di Tella and Juan Cruz Lopez Del Valle

We document the diffusion of nebulized ibuprofen in Argentina as a treatment for COVID-19. As the pandemic spread, this clinically unsupported drug reached thousands of patients, even some seriously ill, despite warnings by the regulator and medical societies. Detailed... View Details

Keywords: COVID-19; Health Care and Treatment; Health Pandemics; Adoption; Behavior; Governing Rules, Regulations, and Reforms; Learning

Register to Read

November 2008 (Revised July 2009)
Background Note

A Managerial Perspective on Clinical Trials

By: Arthur A. Daemmrich

This note describes the history and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70... View Details

Keywords: Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Development; Safety; Biotechnology Industry; Pharmaceutical Industry

Educators